# A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet)

> clinical trial · VERIFIED · 2026-07-14

Status: RECRUITING · Sponsor: AstraZeneca · Condition: Non-Small Cell Lung Cancer

- Company: AstraZeneca
- Sector: Non-Small Cell Lung Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07613424

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.